#BEGIN_DRUGCARD DB04319

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
33980

# Chemical_Formula:
C6H12O5

# Chemical_IUPAC_Name:
(2S,3S,4R,5R,6S)-6-methyloxane-2,3,4,5-tetrol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
6-Deoxyglucose

# HET_ID:
GLW

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C6H12O5/c1-2-3(7)4(8)5(9)6(10)11-2/h2-10H,1H3/t2-,3-,4+,5-,6-/m0/s1

# InChI_Key:
InChIKey=SHZGCJCMOBCMKK-QYESYBIKSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4319

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
164.1565

# Molecular_Weight_Mono:
164.068473494

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1A47

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.4

# Predicted_LogS:
0.7

# Predicted_Water_Solubility:
8.27e+02 g/l

# Primary_Accession_No:
DB04319

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
6713579

# PubChem_Substance_ID:
46507501

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01615

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C[C@@H]1O[C@H](O)[C@@H](O)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:12 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Periplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M57692

# Drug_Target_1_GenBank_ID_Protein:
1004352

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
amyA

# Drug_Target_1_Gene_Sequence:
>2133 bp
ATGAAAAAAACGTTTAAATTGATATTGGTGCTGATGCTTTCACTTACACTTGTTTTTGGA
TTGACAGCACCAATACAGGCAGCTTCTGATACAGCAGTAAGTAATGTTGTCAATTACTCG
ACGGATGTAATTTATCAGATTGTCACTGATAGATTTGTTGATGGAAATACCAGCAACAAT
CCAACTGGTGATTTGTATGATCCAACACATACAAGTCTGAAAAAGTACTTTGGTGGAGAC
TGGCAGGGTATTATTAACAAGATAAATGATGGTTATCTAACAGGAATGGGTGTAACAGCA
ATTTGGATATCTCAGCCTGTAGAAAATATTTATGCAGTCTTACCTGATTCAACTTTTGGT
GGAAGTACATCGTACCATGGTTATTGGGCTCGTGATTTTAAGAGAACAAATCCATACTTT
GGAAGCTTTACTGATTTTCAAAATTTGATTAATACAGCTCATGCACATAACATAAAAGTA
ATTATCGATTTTGCACCAAATCATACTTCACCTGCATCTGAAACCGATCCGACTTATGCT
GAAAATGGAAGGCTATACGACAATGGAACATTACTTGGTGGGTATACAAATGATACAAAC
GGGTATTTTCATCATTATGGAGGAACAGATTTTTCATCTTATGAAGATGGCATTTATCGT
AACTTATTTGATTTAGCAGATTTAAATCAACAGAATAGTACAATCGATTCATACTTAAAA
TCAGCAATTAAGGTGTGGCTCGATATGGGAATAGACGGTATACGTCTAGATGCTGTAAAA
CATATGCCGTTTGGATGGCAGAAGAATTTTATGGATAGCATATTGAGCTATAGGCCTGTA
TTTACATTTGGAGAGTGGTTTCTTGGAACGAATGAAATTGATGTAAATAACACATACTTT
GCAAATGAAAGCGGTATGAGTCTTTTGGACTTTAGGTTTTCTCAAAAAGTGAGGCAGGTA
TTTAGGGATAATACGGATACTATGTATGGACTTGATTCAATGATTCAATCAACTGCATCT
GATTATAATTTTATAAATGATATGGTTACTTTTATTGATAATCATGATATGGATAGATTC
TATAATGGTGGTTCTACTCGTCCAGTTGAACAAGCATTAGCATTTACTTTGACTTCGAGG
GGAGTACCTGCTATATATTATGGAACAGAACAGTATATGACAGGCAATGGAGACCCTTAT
AATAGAGCTATGATGACCTCATTTAATACATCAACTACAGCATATAATGTAATTAAAAAA
CTTGCTCCTTTGCGCAAATCTAATCCTGCAATTGCTTATGGTACTACTCAGCAACGTTGG
ATAAACAATGATGTTTATATATATGAAAGAAAATTTGGGAATAATGTTGCTCTTGTTGCT
ATAAATAGAAATCTTTCAACAAGTTATAATATAACAGGACTGTATACAGCGCTTCCTGCT
GGTACTTATACTGATGTTCTTGGTGGACTTTTAAATGGTAATAGTATTTCTGTCGCGAGT
GATGGTTCTGTAACACCATTTACACTTAGTGCCGGTGAAGTTGCAGTATGGCAGTATGTA
AGTTCAAGTAATTCTCCGTTGATAGGACATGTTGGGCCAACAATGACAAAAGCAGGGCAA
ACTATAACAATAGATGGAAGAGGTTTTGGTACGACATCAGGACAAGTTTTGTTTGGTTCG
ACGGCTGGTACTATTGTCTCTTGGGATGATACAGAGGTAAAAGTAAAAGTTCCTTCGGTG
ACACCTGGTAAATATAATATATCATTAAAAACTTCAAGTGGTGCTACAAGCAATACTTAT
AATAATATTAACATTCTTACAGGCAATCAGATATGTGTTAGATTTGTTGTAAATAATGCA
AGTACAGTGTATGGAGAGAATGTTTATCTTACTGGTAATGTAGCTGAATTGGGAAACTGG
GATACGTCAAAAGCAATAGGACCAATGTTTAATCAGGTAGTATATCAGTATCCTACATGG
TATTATGATGTAAGTGTTCCAGCGGGTACAACAATACAATTTAAGTTTATAAAGAAAAAT
GGCAATACGATAACATGGGAAGGTGGTAGTAACCATACTTATACAGTTCCATCATCTAGT
ACAGGTACTGTAATTGTAAACTGGCAACAATAG

# Drug_Target_1_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_1_General_References:
1854207	Bahl H, Burchhardt G, Spreinat A, Haeckel K, Wienecke A, Schmidt B, Antranikian G: alpha-Amylase of Clostridium thermosulfurogenes EM1: nucleotide sequence of the gene, processing of the enzyme, and comparison of other alpha-amylases. Appl Environ Microbiol. 1991 May;57(5):1554-9.
1874408	Bahl H, Burchhardt G, Wienecke A: Nucleotide sequence of two Clostridium thermosulfurogenes EM1 genes homologous to Escherichia coli genes encoding integral membrane components of binding protein-dependent transport systems. FEMS Microbiol Lett. 1991 Jun 1;65(1):83-7.
7747949	Wind RD, Liebl W, Buitelaar RM, Penninga D, Spreinat A, Dijkhuizen L, Bahl H: Cyclodextrin formation by the thermostable alpha-amylase of Thermoanaerobacterium thermosulfurigenes EM1 and reclassification of the enzyme as a cyclodextrin glycosyltransferase. Appl Environ Microbiol. 1995 Apr;61(4):1257-65.
8604143	Knegtel RM, Wind RD, Rozeboom HJ, Kalk KH, Buitelaar RM, Dijkhuizen L, Dijkstra BW: Crystal structure at 2.3 A resolution and revised nucleotide sequence of the thermostable cyclodextrin glycosyltransferase from Thermonanaerobacterium thermosulfurigenes EM1. J Mol Biol. 1996 Mar 1;256(3):611-22.
9488711	Wind RD, Uitdehaag JC, Buitelaar RM, Dijkstra BW, Dijkhuizen L: Engineering of cyclodextrin product specificity and pH optima of the thermostable cyclodextrin glycosyltransferase from Thermoanaerobacterium thermosulfurigenes EM1. J Biol Chem. 1998 Mar 6;273(10):5771-9.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3207

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
78418

# Drug_Target_1_Name:
Cyclomaltodextrin glucanotransferase

# Drug_Target_1_Number_of_Residues:
710

# Drug_Target_1_PDB_ID:
1CIU

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF00686	CBM_20
PF01833	TIG
PF02806	Alpha-amylase_C

# Drug_Target_1_Protein_Sequence:
>Cyclomaltodextrin glucanotransferase precursor
MKKTFKLILVLMLSLTLVFGLTAPIQAASDTAVSNVVNYSTDVIYQIVTDRFVDGNTSNN
PTGDLYDPTHTSLKKYFGGDWQGIINKINDGYLTGMGVTAIWISQPVENIYAVLPDSTFG
GSTSYHGYWARDFKRTNPYFGSFTDFQNLINTAHAHNIKVIIDFAPNHTSPASETDPTYA
ENGRLYDNGTLLGGYTNDTNGYFHHYGGTDFSSYEDGIYRNLFDLADLNQQNSTIDSYLK
SAIKVWLDMGIDGIRLDAVKHMPFGWQKNFMDSILSYRPVFTFGEWFLGTNEIDVNNTYF
ANESGMSLLDFRFSQKVRQVFRDNTDTMYGLDSMIQSTASDYNFINDMVTFIDNHDMDRF
YNGGSTRPVEQALAFTLTSRGVPAIYYGTEQYMTGNGDPYNRAMMTSFNTSTTAYNVIKK
LAPLRKSNPAIAYGTTQQRWINNDVYIYERKFGNNVALVAINRNLSTSYNITGLYTALPA
GTYTDVLGGLLNGNSISVASDGSVTPFTLSAGEVAVWQYVSSSNSPLIGHVGPTMTKAGQ
TITIDGRGFGTTSGQVLFGSTAGTIVSWDDTEVKVKVPSVTPGKYNISLKTSSGATSNTY
NNINILTGNQICVRFVVNNASTVYGENVYLTGNVAELGNWDTSKAIGPMFNQVVYQYPTW
YYDVSVPAGTTIQFKFIKKNGNTITWEGGSNHTYTVPSSSTGTVIVNWQQ

# Drug_Target_1_Reaction:
Cyclizes part of a 1,4-alpha-D-glucan chain by formation of a 1,4-alpha-D-glucosidic bond

# Drug_Target_1_Signals:
1-27

# Drug_Target_1_Specific_Function:
Degrades starch to alpha-, beta-, and gamma- cyclodextrins, as well as linear sugars

# Drug_Target_1_SwissProt_ID:
P26827

# Drug_Target_1_SwissProt_Name:
CDGT_THETU

# Drug_Target_1_Synonyms:
CGTase
Cyclodextrin-glycosyltransferase
Cyclomaltodextrin glucanotransferase precursor
EC 2.4.1.19

# Drug_Target_1_Theoretical_pI:
5.44

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasmic

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
X78145

# Drug_Target_2_GenBank_ID_Protein:
510492

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
cgt

# Drug_Target_2_Gene_Sequence:
>2142 bp
ATGAAGAAATTTCTGAAATCGACAGCTGCGCTTGCCCTGGGATTATCGCTGACGTTCGGG
CTTTTCAGCCCTGCCCAGGCCGCGCCGGATACCTCGGTATCCAACAAGCAAAATTTCAGC
ACCGACGTCATCTATCAAATTTTCACCGACAGGTTTTCGGACGGCAATCCCGCCAACAAT
CCGACCGGCGCGGCGTTTGACGGAACCTGCACGAACCTCCGGCTGTATTGCGGCGGCGAC
TGGCAGGGCATCATCAACAAAATCAACGACGGTTACCTGACCGGGATGGGCGTTACCGCC
ATCTGGATCTCCCAGCCGGTCGAAAACATCTACAGCATCATCAATTATTCCGGCGTAAAC
AACACGGCCTATCACGGCTACTGGGCCCGGGACTTCAAGAAGACGAATCCGGCCTACGGC
ACGATTGCGGACTTCCAGAACCTGATCGCCGCCGCGCATGCAAAAAACATCAAAGTCATT
ATCGACTTTGCCCCGAACCATACGTCGCCCGCCTCGTCCGACCAGCCTTCCTTTGCGGAA
AACGGCCGGCTGTACGATAACGGCACGCTGCTCGGGGGATACACGAACGATACGCAGAAC
CTGTTCCACCATAACGGCGGCACGGACTTTTCCACGACCGAAAACGGCATCTACAAAAAC
CTGTACGATCTCGCCGACCTGAACCATAACAACAGCACCGTGGACGTCTACTTGAAGGAC
GCGATCAAAATGTGGCTGGACCTCGGCATCGACGGCATCCGCATGGATGCGGTGAAGCAT
ATGCCGTTCGGCTGGCAGAAGAGCTTTATGGCTGCCGTCAACAACTATAAGCCGGTCTTT
ACCTTCGGCGAATGGTTCCTGGGCGTAAATGAAGTGAGCCCGGAAAACCATAAGTTTGCC
AACGAATCCGGCATGAGCCTGCTTGATTTCCGTTTTGCCCAAAAGGTGCGGCAGGTGTTC
CGGGACAACACCGACAATATGTACGGCCTGAAGGCGATGCTGGAGGGCTCCGCAGCCGAT
TACGCCCAGGTGGATGACCAGGTGACGTTCATCGACAACCATGACATGGAGCGTTTCCAC
GCAAGCAATGCAAACCGCCGGAAGCTGGAGCAAGCGCTTGCGTTCACGCTGACCTCGCGC
GGCGTCCCCGCCATTTATTACGGCACCGAGCAGTACATGTCGGGCGGGACCGATCCGGAC
AACCGGGCGCGGATCCCTTCCTTCTCCACGTCGACGACCGCCTATCAGGTCATTCAAAAG
CTGGCGCCGCTGCGCAAGTGCAACCCGGCCATCGCCTACGGATCGACGCAGGAGCGCTGG
ATCAACAACGACGTGCTCATTTATGAGCGCAAATTCGGCAGCAACGTTGCCGTCGTTGCC
GTCAACCGCAATTTAAACGCGCCGGCTTCCATTTCGGGACTTGTCACTTCCCTGCCGCAA
GGCAGCTACAACGACGTCCTTGGCGGCCTTCTGAACGGCAACACGTTATCGGTAGGCTCC
GGCGGGGCCGCCTCCAATTTCACGCTTGCGGCCGGCGGCACGGCGGTGTGGCAGTACACC
GCGGCTACGGCGACGCCGACCATCGGGCATGTCGGGCCGATGATGGCCAAGCCGGGCGTG
ACGATCACGATCGACGGCCGCGGCTTCGGCTCTAGCAAAGGCACCGTCTACTTCGGTACG
ACGGCGGTGAGCGGGGCGGACATCACGTCTTGGGAAGACACGCAGATCAAAGTGAAAATT
CCGGCCGTCGCAGGCGGCAACTACAACATTAAAGTCGCAAACGCTGCCGGAACGGCAAGC
AATGTGTATGACAACTTCGAGGTATTGTCCGGAGACCAGGTCAGCGTCCGCTTCGTGGTC
AACAACGCGACGACGGCCCTTGGGCAAAATGTGTACCTGACGGGCAGTGTCAGCGAGCTG
GGGAACTGGGACCCGGCAAAAGCAATCGGGCCGATGTACAATCAGGTCGTTTACCAATAT
CCGAACTGGTATTATGACGTCAGCGTTCCGGCCGGCAAAACGATCGAGTTCAAGTTTTTG
AAAAAACAAGGCTCCACCGTCACGTGGGAAGGCGGCAGCAACCACACCTTCACCGCGCCG
TCCAGCGGCACCGCGACCATTAACGTGAATTGGCAGCCATAA

# Drug_Target_2_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_2_General_References:
7493956	Knegtel RM, Strokopytov B, Penninga D, Faber OG, Rozeboom HJ, Kalk KH, Dijkhuizen L, Dijkstra BW: Crystallographic studies of the interaction of cyclodextrin glycosyltransferase from Bacillus circulans strain 251 with natural substrates and products. J Biol Chem. 1995 Dec 8;270(49):29256-64.
8107143	Lawson CL, van Montfort R, Strokopytov B, Rozeboom HJ, Kalk KH, de Vries GE, Penninga D, Dijkhuizen L, Dijkstra BW: Nucleotide sequence and X-ray structure of cyclodextrin glycosyltransferase from Bacillus circulans strain 251 in a maltose-dependent crystal form. J Mol Biol. 1994 Feb 18;236(2):590-600.
8672460	Strokopytov B, Knegtel RM, Penninga D, Rozeboom HJ, Kalk KH, Dijkhuizen L, Dijkstra BW: Structure of cyclodextrin glycosyltransferase complexed with a maltononaose inhibitor at 2.6 angstrom resolution. Implications for product specificity. Biochemistry. 1996 Apr 2;35(13):4241-9.
8955113	Penninga D, van der Veen BA, Knegtel RM, van Hijum SA, Rozeboom HJ, Kalk KH, Dijkstra BW, Dijkhuizen L: The raw starch binding domain of cyclodextrin glycosyltransferase from Bacillus circulans strain 251. J Biol Chem. 1996 Dec 20;271(51):32777-84.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2523

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
77310

# Drug_Target_2_Name:
Cyclomaltodextrin glucanotransferase

# Drug_Target_2_Number_of_Residues:
713

# Drug_Target_2_PDB_ID:
2CXG

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF00686	CBM_20
PF01833	TIG
PF02806	Alpha-amylase_C

# Drug_Target_2_Protein_Sequence:
>Cyclomaltodextrin glucanotransferase precursor
MKKFLKSTAALALGLSLTFGLFSPAQAAPDTSVSNKQNFSTDVIYQIFTDRFSDGNPANN
PTGAAFDGTCTNLRLYCGGDWQGIINKINDGYLTGMGVTAIWISQPVENIYSIINYSGVN
NTAYHGYWARDFKKTNPAYGTIADFQNLIAAAHAKNIKVIIDFAPNHTSPASSDQPSFAE
NGRLYDNGTLLGGYTNDTQNLFHHNGGTDFSTTENGIYKNLYDLADLNHNNSTVDVYLKD
AIKMWLDLGIDGIRMDAVKHMPFGWQKSFMAAVNNYKPVFTFGEWFLGVNEVSPENHKFA
NESGMSLLDFRFAQKVRQVFRDNTDNMYGLKAMLEGSAADYAQVDDQVTFIDNHDMERFH
ASNANRRKLEQALAFTLTSRGVPAIYYGTEQYMSGGTDPDNRARIPSFSTSTTAYQVIQK
LAPLRKCNPAIAYGSTQERWINNDVLIYERKFGSNVAVVAVNRNLNAPASISGLVTSLPQ
GSYNDVLGGLLNGNTLSVGSGGAASNFTLAAGGTAVWQYTAATATPTIGHVGPMMAKPGV
TITIDGRGFGSSKGTVYFGTTAVSGADITSWEDTQIKVKIPAVAGGNYNIKVANAAGTAS
NVYDNFEVLSGDQVSVRFVVNNATTALGQNVYLTGSVSELGNWDPAKAIGPMYNQVVYQY
PNWYYDVSVPAGKTIEFKFLKKQGSTVTWEGGSNHTFTAPSSGTATINVNWQP

# Drug_Target_2_Reaction:
Cyclizes part of a 1,4-alpha-D-glucan chain by formation of a 1,4-alpha-D-glucosidic bond

# Drug_Target_2_Signals:
1-27

# Drug_Target_2_Specific_Function:
Cyclizes part of a 1,4-alpha-D-glucan chain by formation of a 1,4-alpha-D-glucosidic bond

# Drug_Target_2_SwissProt_ID:
P43379

# Drug_Target_2_SwissProt_Name:
CDGT2_BACCI

# Drug_Target_2_Synonyms:
CGTase
Cyclodextrin-glycosyltransferase
Cyclomaltodextrin glucanotransferase precursor
EC 2.4.1.19

# Drug_Target_2_Theoretical_pI:
6.52

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB04319
